Sub Pages
News, Press Releases & Press Articles
Quotient Bioresearch Acquires Edinburgh Research Facility
Date: 18/05/2009
CAMBRIDGESHIRE, UK, 18th May 2009 – Quotient Bioresearch Limited ("Quotient"), a leading provider of drug development services, today announces that it has acquired Charles River Laboratories' (Charles River) Edinburgh clinical research facility. This represents the sixth acquisition in approximately three years for Quotient.Download Document: QuotientClinicalAnnouncment1805091.pdf (79.4 KB)
Archive
- 2012 March (1)
- 2012 January (1)
- 2010 July (1)
- 2010 May (1)
- 2009 May (1)
- 2009 April (1)
- 2008 December (2)
- 2008 September (6)
- 2008 August (1)
- 2008 July (1)
- 2008 June (1)
- 2008 May (2)
- 2008 April (1)
- 2008 March (1)
- 2008 February (2)
- 2008 January (3)
- 2007 September (1)
- 2007 August (1)
- 2007 May (1)
- 2007 March (1)
